Krajewska et al. (1996),1 studying the expression of the bcl-2 family in prostate cancer (genes bax, bcl-x and mcl-1) correlated to the Gleason score, verified that the stage progression and the score increase are positively related to the increase in the expression of these genes. This evidence concerns the gene BCL2L1 and prostate carcinoma.